• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】30898

【品名】(2S)-2-amino-5-[[(benzyloxy)carbonyl]amino]pentanoic acid

【CA登记号】

【 分 子 式 】C13H18N2O4

【 分 子 量 】266.297

【元素组成】C 58.63% H 6.81% N 10.52% O 24.03%

与该中间体有关的原料药合成路线共 4 条

合成路线1

该中间体在本合成路线中的序号:(I)

Conversion of amino acid (I) into its methyl ester derivative (II) by means of SOCl2 in MeOH, followed by coupling with ethyl isocyanatoacetate (III) and Et3N in CH2Cl2/THF yields derivative (IV). Cyclization of (IV) by means of H2O/HCl affords hydantoin (V), which reacts with 2-methylthio-2-imidazoline (VI) in an aqueous NaOH solution to provide cyclic guanidine derivative (VII). Treatment of amino acid (VIII) with isobutylene (IX) and H2SO4 in dioxane affords t-Bu ester (X), which then couples with (VII) by means of HOBt and DCC in DMF to furnish derivative (XI). Finally, tert-butyl ester is hydrolyzed by treatment with TFA in the presence of 1,2-dimercaptoethane.

1 Knolle, J.; Peyman, A.; Wehner, V.; et al.; RGD mimetics containing a central hydantoin scaffold: alphavbeta3 vs alphaIIbbeta3 selective requirements. Bioorg Med Chem Lett 2000, 10, 2, 179.
2 Wehner, V.; Knolle, J.; Stilz, H.U.; Carniato, D.; Gourvest, J.-F.; Gadek, T.; McDowell, R. (Aventis SA); Inhibitors of bone resorption and vitronectin receptor antagonists. DE 19626701; DE 19635522; EP 0796855 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 30898 (2S)-2-amino-5-[[(benzyloxy)carbonyl]amino]pentanoic acid C13H18N2O4 详情 详情
(II) 42993 methyl (2S)-2-amino-5-[[(benzyloxy)carbonyl]amino]pentanoate C14H20N2O4 详情 详情
(III) 18312 ETHYL ISOCYANATOACETATE; ethyl 2-isocyanatoacetate 2949-22-6 C5H7NO3 详情 详情
(IV) 42994 12-ethyl 8-methyl (8S)-3,10-dioxo-1-phenyl-2-oxa-4,9,11-triazadodecane-8,12-dicarboxylate C19H27N3O7 详情 详情
(V) 42295 (2R)-N-methyl-2-(methylamino)-3-(2-naphthyl)-N-[(1R)-2-oxo-1-(2-thienylmethyl)-2-(1,2,2-trimethylhydrazino)ethyl]propanamide C25H32N4O2S 详情 详情
(VI) 42996 4,5-dihydro-1H-imidazol-2-yl methyl sulfide; 2-(methylsulfanyl)-4,5-dihydro-1H-imidazole 5464-11-9 C4H8N2S 详情 详情
(VII) 42997 2-[(4S)-4-[3-(4,5-dihydro-1H-imidazol-2-ylamino)propyl]-2,5-dioxoimidazolidinyl]acetic acid C11H17N5O4 详情 详情
(VIII) 18008 (2S)-3-amino-2-[[(benzyloxy)carbonyl]amino]propionic acid; N(alpha)-Z-L-2,3-diaminopropionic acid 35761-26-3 C11H14N2O4 详情 详情
(IX) 15926 2-methyl-1-propene; isobutylene 115-11-7 C4H8 详情 详情
(X) 18009 tert-butyl (2S)-3-amino-2-[[(benzyloxy)carbonyl]amino]propanoate C15H22N2O4 详情 详情
(XI) 42998 tert-butyl (2S)-2-[[(benzyloxy)carbonyl]amino]-3-[(2-[(4S)-4-[3-(4,5-dihydro-1H-imidazol-2-ylamino)propyl]-2,5-dioxoimidazolidinyl]acetyl)amino]propanoate C26H37N7O7 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

The fully protection of Nomega-(benzyloxycarbonyl)-L-ornithine (I) by usual methods gives Nomega-(benzyloxycarbonyl)-Nalpha-(tert-butoxycarbonyl)-L-ornithine tert-butyl ester (II), which is selectively deprotected at the omega amino group with H2 over Pd/C yielding the ornithine (III). The reaction of (III) with thiophosgene affords the isothiocyanate (IV), which is treated with hydrazine to afford the aminothiourea (V). Finally, this compound is deprotected with 4M HCl.

1 Ichimori, K.; Stuehr, D.J.; Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase. J Med Chem 1999, 42, 10, 1842.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 30898 (2S)-2-amino-5-[[(benzyloxy)carbonyl]amino]pentanoic acid C13H18N2O4 详情 详情
(II) 30899 tert-butyl (2S)-5-[[(benzyloxy)carbonyl]amino]-2-[(tert-butoxycarbonyl)amino]pentanoate C22H34N2O6 详情 详情
(III) 30900 tert-butyl (2S)-5-amino-2-[(tert-butoxycarbonyl)amino]pentanoate C14H28N2O4 详情 详情
(IV) 30901 tert-butyl (2S)-2-[(tert-butoxycarbonyl)amino]-5-isothiocyanatopentanoate C15H26N2O4S 详情 详情
(V) 30904 tert-butyl (2S)-2-[(tert-butoxycarbonyl)amino]-5-[(hydrazinocarbothioyl)amino]pentanoate C15H30N4O4S 详情 详情

合成路线3

该中间体在本合成路线中的序号:(I)

The fully protection of Nomega-(benzyloxycarbonyl)-L-ornithine (I) by usual methods gives Nomega-(benzyloxycarbonyl)-Nalpha-(tert-butoxycarbonyl)-L-ornithine tert-butyl ester (II), which is selectively deprotected at the omega amino group with H2 over Pd/C yielding the ornithine (III). The reaction of (III) with thiophosgene affords the isothiocyanate (IV), which is treated with hydroxylamine to afford the hydroxythiourea (V). The methylation of (V) with methyl iodide and NaH affords the S-methyl derivative (VI), which is finally deprotected with 4M HCl.

1 Ichimori, K.; Stuehr, D.J.; Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase. J Med Chem 1999, 42, 10, 1842.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 30898 (2S)-2-amino-5-[[(benzyloxy)carbonyl]amino]pentanoic acid C13H18N2O4 详情 详情
(II) 30899 tert-butyl (2S)-5-[[(benzyloxy)carbonyl]amino]-2-[(tert-butoxycarbonyl)amino]pentanoate C22H34N2O6 详情 详情
(III) 30900 tert-butyl (2S)-5-amino-2-[(tert-butoxycarbonyl)amino]pentanoate C14H28N2O4 详情 详情
(IV) 30901 tert-butyl (2S)-2-[(tert-butoxycarbonyl)amino]-5-isothiocyanatopentanoate C15H26N2O4S 详情 详情
(V) 30902 tert-butyl (2S)-2-[(tert-butoxycarbonyl)amino]-5-[[(hydroxyamino)carbothioyl]amino]pentanoate C15H29N3O5S 详情 详情
(VI) 30903 tert-butyl (2S)-2-[(tert-butoxycarbonyl)amino]-5-[[(Z)-(hydroxyamino)(methylsulfanyl)methylidene]amino]pentanoate C16H31N3O5S 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

The fully protection of Nomega-(benzyloxycarbonyl)-L-ornithine (I) by usual methods gives Nomega-(benzyloxycarbonyl)-Nalpha-(tert-butoxycarbonyl)-L-ornithine tert-butyl ester (II), which is selectively deprotected at the omega amino group with H2 over Pd/C yielding the ornithine (III). The reaction of (III) with thiophosgene affords the isothiocyanate (IV), which is treated with hydrazine to afford the aminothiourea (V). The methylation of (V) with methyl iodide and NaH affords the S-methyl derivative (VI), which is finally deprotected with 4M HCl.

1 Ichimori, K.; Stuehr, D.J.; Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase. J Med Chem 1999, 42, 10, 1842.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 30898 (2S)-2-amino-5-[[(benzyloxy)carbonyl]amino]pentanoic acid C13H18N2O4 详情 详情
(II) 30899 tert-butyl (2S)-5-[[(benzyloxy)carbonyl]amino]-2-[(tert-butoxycarbonyl)amino]pentanoate C22H34N2O6 详情 详情
(III) 30900 tert-butyl (2S)-5-amino-2-[(tert-butoxycarbonyl)amino]pentanoate C14H28N2O4 详情 详情
(IV) 30901 tert-butyl (2S)-2-[(tert-butoxycarbonyl)amino]-5-isothiocyanatopentanoate C15H26N2O4S 详情 详情
(V) 30904 tert-butyl (2S)-2-[(tert-butoxycarbonyl)amino]-5-[(hydrazinocarbothioyl)amino]pentanoate C15H30N4O4S 详情 详情
(VI) 30905 tert-butyl (2S)-2-[(tert-butoxycarbonyl)amino]-5-[[(Z)-hydrazino(methylsulfanyl)methylidene]amino]pentanoate C16H32N4O4S 详情 详情
Extended Information